The global cyanocobalamin injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Cyanocobalamin is defined as a vitamin found in foods of animal origin such as liver, fish, and eggs, a deficiency of which can cause pernicious anemia. It contains a cyanide group bonded to the central cobalt atom of a cobalamin molecule. The market growth is majorly attributed to the increasing prevalence of paranoia, depression and bipolarity, and memory loss which are a result of deficiency of cyanocobalamin. As per the Institute for Health Metrics and Evaluation (IHME), Global Burden of Diseases, the typical age of onset of bipolar disorder is the late teens or the early 20s, and a history of depression is common in people diagnosed with bipolarity. Thus, in order to avoid the prevalence of such medical conditions among people, the demand for cyanocobalamin injections is likely to grow, thereby boosting the global cyanocobalamin injection market.

Another key trend observed in the market includes the growing adoption of a vegan diet. Although veganism and the trend of vegetarian food have vastly affected the socioeconomics, it has also led to the lack of specific nutrients, for instance, nutrient B12 among the affected population. cyanocobalamin is the manufactured type of nutrient B12, whose deficiency may cause anemia (as nutrient B12 supports in the development of red platelets in the bone marrow). To supplement this lack, cyanocobalamin injections are adopted as effective sources to meet the insufficiency of vitamin B12.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Product Type
• By Application

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  Merck & Co., Inc., and Mylan NV, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cyanocobalamin Injection Market Report by Segment

By Product Type

• 10 ML
• 30 ML
• Others

By Application

• Hospitals
• Clinics
• Others

Global Cyanocobalamin Injection Market Report by Region

North America       

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa